assembly_id	genome_id	genome_def	crispr_array_locus_merge	crispr_array_location_merge	crispr_locus_id	crispr_pred_method	array_in_prot	prot_within_array_20000	prot_in_genome	crispr_type_by_cas_prot	consensus_repeat	repeat_length	self-targeting_spacer_number	self-targeting_target_number	spacer_location	protospacer_location	repeat_type	spacer_locus_num	spacer_num	correct_crispr_type	genome_cas_prots	unknown_protein_around_crispr	L10	L10_domain	L9	L9_domain	L8	L8_domain	L7	L7_domain	L6	L6_domain	L5	L5_domain	L4	L4_domain	L3	L3_domain	L2	L2_domain	L1	L1_domain	R1	R1_domain	R2	R2_domain	R3	R3_domain	R4	R4_domain	R5	R5_domain	R6	R6_domain	R7	R7_domain	R8	R8_domain	R9	R9_domain	R10	R10_domain
GCF_000020065.1_ASM2006v1	NC_011025	Mycoplasma arthritidis 158L3-1, complete sequence	1	539513-541733	1,1,1	PILER-CR,CRISPRCasFinder,CRT	no	cas1,cas2,csn2,cas9	cas1,cas2,csn2,cas9,DEDDh	Type II-A,Type II-C,Type II-B	ACTTTTGGACTGTACAATTTTTATATAGAGTAAAG,ACTTTTGGACTGTACAATTTTTATATAGAGTAAAGT,ACTTTTGGACTGTACAATTTTTATATAGAGTAAAGT	35,36,36	7	7	540343-540373|540409-540439|540871-540901|540344-540373|540410-540439|540872-540901|541203-541232	NC_011025.1_167532-167502|NC_011025.1_720690-720660|NC_011025.1_709886-709856|NC_011025.1_167531-167502|NC_011025.1_720689-720660|NC_011025.1_709885-709856|NC_011025.1_711323-711294	NA:NA:NA	32,33,33	33	TypeII-A,TypeII-C,TypeII-B	cas1,cas2,csn2,cas9,DEDDh	NA|127aa|up_8|NC_011025.1_530770_531151_+,NA|329aa|up_7|NC_011025.1_531129_532116_+,NA|103aa|up_6|NC_011025.1_532856_533165_+,NA|230aa|up_5|NC_011025.1_533172_533862_+,csn2|259aa|up_0|NC_011025.1_538729_539506_+,NA|304aa|down_9|NC_011025.1_555648_556560_+	NA|890aa|up_9|NC_011025.1_527767_530437_-	PRK05743, ileS, isoleucyl-tRNA synthetase; Reviewed	NA|127aa|up_8|NC_011025.1_530770_531151_+	NA	NA|329aa|up_7|NC_011025.1_531129_532116_+	NA	NA|103aa|up_6|NC_011025.1_532856_533165_+	NA	NA|230aa|up_5|NC_011025.1_533172_533862_+	NA	NA|534aa|up_4|NC_011025.1_533972_535574_-	PRK05380, pyrG, CTP synthetase; Validated	NA|503aa|up_3|NC_011025.1_535817_537326_+	PRK05434, PRK05434, 2,3-bisphosphoglycerate-independent phosphoglycerate mutase	cas1|298aa|up_2|NC_011025.1_537523_538417_+	TIGR03639, cas1_NMENI, CRISPR-associated endonuclease Cas1, subtype II/NMENI	cas2|111aa|up_1|NC_011025.1_538397_538730_+	COG3512, COG3512, CRISPR-associated protein, Cas2 homolog [Defense mechanisms]	csn2|259aa|up_0|NC_011025.1_538729_539506_+	NA	NA|85aa|down_0|NC_011025.1_541842_542097_+	COG3505, VirD4, Type IV secretory pathway, VirD4 components [Intracellular trafficking and secretion]	cas9|906aa|down_1|NC_011025.1_542882_545600_-	cd09643, Csn1, CRISPR/Cas system-associated protein Cas9	cas9|394aa|down_2|NC_011025.1_545620_546802_-	TIGR01865, conserved_hypothetical_protein, CRISPR subtype II/NMENI RNA-guided endonuclease Cas9/Csn1	NA|153aa|down_3|NC_011025.1_547506_547965_-	pfam01741, MscL, Large-conductance mechanosensitive channel, MscL	NA|172aa|down_4|NC_011025.1_548158_548674_+	PRK02304, PRK02304, adenine phosphoribosyltransferase; Provisional	NA|612aa|down_5|NC_011025.1_548678_550514_+	cd09608, M3B_PepF, Peptidase family M3B, oligopeptidase F (PepF)	NA|1000aa|down_6|NC_011025.1_550601_553601_+	PRK07135, dnaE, DNA polymerase III DnaE; Validated	NA|294aa|down_7|NC_011025.1_553590_554472_+	PRK05755, PRK05755, DNA polymerase I; Provisional	NA|294aa|down_8|NC_011025.1_554740_555622_+	COG3611, DnaB, Replication initiation/membrane attachment protein [DNA replication, recombination, and repair]	NA|304aa|down_9|NC_011025.1_555648_556560_+	NA
GCF_000020065.1_ASM2006v1	NC_011025	Mycoplasma arthritidis 158L3-1, complete sequence	2	694639-694737	2	CRISPRCasFinder	no	DEDDh	cas1,cas2,csn2,cas9,DEDDh	Unclear	TGAAGGGAATCGGACCCTCGTATT	24	0	0	NA	NA	NA	1	1	Orphan	cas1,cas2,csn2,cas9,DEDDh	NA|98aa|up_5|NC_011025.1_689902_690196_-,NA|173aa|up_3|NC_011025.1_691516_692035_-,NA|618aa|up_1|NC_011025.1_692376_694230_-,NA|68aa|up_0|NC_011025.1_694230_694434_-,NA|126aa|down_7|NC_011025.1_705544_705922_+,NA|132aa|down_8|NC_011025.1_706095_706491_+	NA|348aa|up_9|NC_011025.1_685417_686461_-	cd08297, CAD3, Cinnamyl alcohol dehydrogenases (CAD)	NA|244aa|up_8|NC_011025.1_686501_687233_-	TIGR02191, Ribonuclease_3, ribonuclease III, bacterial	NA|334aa|up_7|NC_011025.1_687239_688241_-	PRK05331, PRK05331, phosphate acyltransferase PlsX	NA|547aa|up_6|NC_011025.1_688259_689900_-	TIGR03599, YloV, DAK2 domain fusion protein YloV	NA|98aa|up_5|NC_011025.1_689902_690196_-	NA	NA|420aa|up_4|NC_011025.1_690211_691471_-	PRK00011, glyA, serine hydroxymethyltransferase; Reviewed	NA|173aa|up_3|NC_011025.1_691516_692035_-	NA	NA|56aa|up_2|NC_011025.1_692193_692361_-	pfam04200, Lipoprotein_17, Lipoprotein associated domain	NA|618aa|up_1|NC_011025.1_692376_694230_-	NA	NA|68aa|up_0|NC_011025.1_694230_694434_-	NA	NA|174aa|down_0|NC_011025.1_695335_695857_-	COG0350, Ada, Methylated DNA-protein cysteine methyltransferase [DNA replication, recombination, and repair]	NA|335aa|down_1|NC_011025.1_695914_696919_-	TIGR01534, Glyceraldehyde-3-phosphate_dehydrogenase, glyceraldehyde-3-phosphate dehydrogenase, type I	NA|299aa|down_2|NC_011025.1_697006_697903_-	PRK13671, PRK13671, nucleotidyltransferase	NA|562aa|down_3|NC_011025.1_698064_699750_-	pfam13520, AA_permease_2, Amino acid permease	NA|450aa|down_4|NC_011025.1_700132_701482_-	COG2265, TrmA, SAM-dependent methyltransferases related to tRNA (uracil-5-)-methyltransferase [Translation, ribosomal structure and biogenesis]	NA|443aa|down_5|NC_011025.1_701484_702813_-	PRK05291, trmE, tRNA uridine-5-carboxymethylaminomethyl(34) synthesis GTPase MnmE	NA|765aa|down_6|NC_011025.1_703094_705389_+	COG1263, PtsG, Phosphotransferase system IIC components, glucose/maltose/N-acetylglucosamine-specific [Carbohydrate transport and metabolism]	NA|126aa|down_7|NC_011025.1_705544_705922_+	NA	NA|132aa|down_8|NC_011025.1_706095_706491_+	NA	NA|277aa|down_9|NC_011025.1_706928_707759_+	cd00984, DnaB_C, DnaB helicase C terminal domain
